Skip to main content
Medicure Inc logo

Medicure Inc — Investor Relations & Filings

Ticker · MPH ISIN · CA58469E4085 LEI · 9845007T999BF377B627 TSXV Manufacturing
Open in API
Filings indexed 293 across all filing types
Latest filing 2022-05-31 Regulatory Filings
Country CA Canada
Listing TSXV MPH

About Medicure Inc

https://www.medicure.com/

Medicure Inc. is a value-based pharmaceutical company specializing in the research, clinical development, and commercialization of human therapeutics. The company is primarily focused on developing and commercializing innovative and affordable medicines within the cardiovascular therapeutic area. Medicure's core mission is to serve patients by delivering safe and efficacious life-changing medicines, with a strategic focus on the U.S. market. It aims to offer a growing portfolio of products and services, ensuring patient access to necessary care.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2022-05-31 English
News release - English.pdf
Regulatory Filings
2022-05-31 English
Annual report on form 20-F - English.pdf
Annual Report Classification · 100% confidence The document is a Form 20-F filed with the United States Securities and Exchange Commission (SEC) for the fiscal year ended December 31, 2021. Form 20-F is an annual report filed by foreign private issuers, similar to the 10-K filed by U.S. companies. The text includes detailed sections such as financial data, business overview, directors and management, major shareholders, and financial statements, which are typical components of a comprehensive annual report. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or certification. Therefore, the document fits the definition of an Annual Report (10-K equivalent for foreign issuers). FY 2021
2022-04-28 English
Annual MD&A - English.pdf
Regulatory Filings Classification · 95% confidence The document is a certification statement by the CFO of Alphinat Inc. regarding the review and fair presentation of the interim financial report and interim MD&A for the period ended February 28, 2022. It is titled as a 'FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE' and explicitly states it is a certification of interim filings, not the filings themselves. The document does not contain actual financial data or substantive financial analysis but is an officer certification related to interim filings. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3012 characters), consistent with a certification letter rather than a full interim report.
2022-04-28 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the President & Interim CFO of Medicure Inc. It certifies the review and fair presentation of the annual filings for the financial year ended December 31, 2021. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It references the annual filings but does not include them. The document length is 3165 characters, which is relatively short and consistent with a certification letter rather than a full report. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the Annual Report (10-K) or other financial reports.
2022-04-28 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CEO. It certifies the review and fair presentation of the annual filings for the financial year ended December 31, 2021. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It references the annual filings but does not include them. According to the CERTIFICATION RULE, such certification documents should be classified as Regulatory Filings (RNS) rather than the actual Annual Report (10-K) or other financial reports. The document length is 3142 characters, which is relatively short and consistent with a certification letter rather than a full report.
2022-04-28 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.